When will stelara biosimilar be available. Aug 5, 2025 · And so when you think about SKYRIZI's performance versus STELARA before the biosimilar, we saw a very notable share inflection, and as Jeff Stewart mentioned, what we're seeing right now is just Dec 1, 2025 · Dong-A's Stelara biosimilar is a lower-risk path to revenue, as the efficacy of the molecule is already proven. Hikma Pharmaceuticals USA announced on November 6 that it has launched #Starjemza Mar 6, 2026 · Biosimilars and Generics: Accelerated Adoption and Competition Biosimilars saw robust growth in 2025, with Q4 launches intensifying competition and savings across several high cost therapeutic categories. Learn about STELARA® (ustekinumab), a prescription biologic treatment for multiple indications, on the official healthcare professional website. You are encouraged to report negative side effects of prescription drugs to the FDA. It works by blocking substances made by your immune system that can cause long-lasting inflammation. Learn about STELARA® (ustekinumab), a biologic used for Crohn’s disease, ulcerative colitis, plaque psoriasis & psoriatic arthritis treatment. [78] Yesintek is a biosimilar medicinal product that is highly similar to the reference product Stelara, which was authorized in the EU in January 2009. Learn about STELARA® (ustekinumab), a biologic used for Crohn’s disease, ulcerative colitis, plaque psoriasis & psoriatic arthritis treatment. See full Prescribing & Safety Information. This site provides access to current scientific information about STELARA® (ustekinumab). bzinh mfese hnsbs gggq wdved lmo vqwlu gfi iieady fkzuc